| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18812485 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Ono M, Miki N, Kawamata T, et al.
Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2008 Sep 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Verhelst J, Abs R, Maiter D, et al.
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. [Journal Article]
J Clin Endocrinol Metab 1999 Jul; 84(7):2518-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Webster J, Piscitelli G, Polli A, et al.
The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. [Clinical Trial, Journal Article, Multicenter Study]
Clin Endocrinol (Oxf) 1993 Sep; 39(3):323-9.
Abstract | Full Citation | Find Related Articles | | Colao A, Sarno AD, Cappabianca P, et al.
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. [Clinical Trial, Journal Article]
Eur J Endocrinol 2003 Mar; 148(3):325-31.
Abstract | Full Citation | Find Related Articles | | Webster J, Piscitelli G, Polli A, et al.
Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Endocrinol (Oxf) 1992 Dec; 37(6):534-41.
Abstract | Full Citation | Find Related Articles | | Corsello SM, Ubertini G, Altomare M, et al.
Giant prolactinomas in men: efficacy of cabergoline treatment. [Journal Article]
Clin Endocrinol (Oxf) 2003 May; 58(5):662-70.
Abstract | Full Citation | Find Related Articles | | Ferrari CI, Abs R, Bevan JS, et al.
Treatment of macroprolactinoma with cabergoline: a study of 85 patients. [Journal Article, Multicenter Study]
Clin Endocrinol (Oxf) 1997 Apr; 46(4):409-13.
Abstract | Full Citation | Find Related Articles | | Biller BM, Molitch ME, Vance ML, et al.
Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. [Journal Article]
J Clin Endocrinol Metab 1996 Jun; 81(6):2338-43.
Abstract | Full Citation | Find Related Articles | | Colao A, Ferone D, Lastoria S, et al.
Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Endocrinol (Oxf) 2000 Apr; 52(4):437-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
